New insights in Poor responder and PCOS patients - Reproductive ...

Aim of the course
The course offers an overview on two important aspects of reproductive
medicine: polycystic ovary syndrome (PCOS) and poor ovarian response
(POR). Both these conditions have a high impact on daily practice and
represent a challenge for reproductive physicians. This meeting is
dedicated to providing new insights on these topics, with an interactive
program where each lecture is followed by specific cases studies and
working groups in order to provide participants with both up-to-date
knowledge and the possibility to share their experiences each other’s
and with the speakers.
Learning objectives
At the end of the course participants will be able to:
• Identify current evidence-based recommendation to achieve the best
management in PCOS and POR patients
• Tailoring the best protocol for patients undergoing ART
• Minimize the risks of OHSS in PCOS patients undergoing ART
Target audience
This program is designed for clinicians working in assisted reproductive
medicine, who want to acquire up-to date information for improving their
current clinical practice.
Accreditation
An application has been made to the EACCME ® for CME accreditation of
the Serono Symposia International Foundation course “New insights in
Poor responder and PCOS patients: a personalized approach” on
November 29-30, 2012 in Dubai, United Arab Emirates.
All Serono Symposia International Foundation programmes are organized solely to
promote the exchange and dissemination of scientific and medical information. No forms
of promotional activities are permitted. All Serono Symposia International Foundation
programmes are made possible thanks to the unrestricted Educational grants received
from: Arseus Medical, Besins Healthcare, Celgene, Centre d’Esclerosi Multiple de
Catalunya (Vall d'Hebron University Hospital), ComtecMed, Congrex, Croissance Conseil,
Cryo-Save, Datanalysis, Dos33, Esaote, European Society of Endocrinology, Ferring,
Fondazione Humanitas, Fundación IVI, GE Healthcare, GlaxoSmithKline Pharmaceuticals,
IPSEN, Johnson & Johnson Medical, ISFP International Society for Fertility Preservation,
ISMH International Society of Men’s Health, K.I.T.E., Karl Storz, Lumenis, Merck Serono
Group, PregLem, Richard Wolf Endoscopie, Sanofi-Aventis, Stallergenes, Stopler, Teva
Pharma, Toshiba Medical Systems, Université Catholique de Louvain (UCL), University of
Catania.
2